Morgenroth, Sarah
Roggo, Andrea
Pawlik, Laura
Dummer, Reinhard
Ramelyte, Egle http://orcid.org/0000-0001-8262-8608
Funding for this research was provided by:
University of Zurich
Article History
Accepted: 25 September 2023
First Online: 24 October 2023
Declarations
:
: Prof. Dummer has intermittent, project -focused consulting and/or advisory relationships with Novartis, Merck Sharp & Dohme (MSD), Bristol-Myers Squibb (BMS), Roche, Amgen, Takeda, Pierre Fabre, Sun Pharma, Sanofi, Catalym, Second Genome, Regeneron, Alligator, T3 Pharma, MaxiVAX SA, Pfizer, Simcere, and touchIME outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.